Savara (SVRA) Other Non-Current Assets (2010 - 2026)

Savara (SVRA) reported Other Non-Current Assets of $11.4 million for Q1 2026, up 5.88% year-over-year from $10.7 million in Q1 2025, and down 2.34% quarter-over-quarter from $11.6 million in Q4 2025.

Savara (SVRA) Other Non-Current Assets (2010 - 2026) Analysis & Trends

Savara (SVRA) has 17 years of Other Non-Current Assets data on file, last reported at $11.4 million in Q1 2026.

  • Other Non-Current Assets for Q1 2026 came in at $11.4 million, up 5.88% year-over-year; the trailing twelve-month figure through Mar 2026 was $11.4 million (up 5.88% YoY), and the FY2025 annual result was $11.6 million, up 12.97% from the prior year.
  • Other Non-Current Assets fell to $11.4 million in Q1 2026 per SVRA's latest filing, from $11.6 million in the prior quarter.
  • Over five years, Other Non-Current Assets peaked at $11.6 million in Q4 2025 and troughed at $116000.0 in Q4 2022.
  • A 5-year average of $6.7 million and a median of $10.3 million in 2024 frame the typical range for Other Non-Current Assets.
  • The sharpest annual moves came in 2022 and 2023: Other Non-Current Assets slumped 98.97% in 2022, then jumped 9348.28% in 2023.
  • A 5-year view of Other Non-Current Assets shows it stood at $116000.0 in 2022, then jumped by 9348.28% to $11.0 million in 2023, then retreated by 6.02% to $10.3 million in 2024, then grew by 12.97% to $11.6 million in 2025, then dropped by 2.34% to $11.4 million in 2026.
  • Business Quant data shows SVRA's Other Non-Current Assets at $11.4 million in Q1 2026, $11.6 million in Q4 2025, and $990000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 289.41 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 12.40 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 60,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 1.26 Bn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Savara 1.39 Bn 1.39 Bn - 11.36 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 11.36 Mn
Dec 31, 2025 11.64 Mn
Sep 30, 2025 990,000.00
Jun 30, 2025 1.03 Mn
Mar 31, 2025 10.73 Mn
Dec 31, 2024 10.30 Mn
Sep 30, 2024 11.11 Mn
Jun 30, 2024 10.63 Mn
Mar 31, 2024 1.15 Mn
Dec 31, 2023 10.96 Mn
Sep 30, 2023 10.50 Mn
Jun 30, 2023 888,000.00
Mar 31, 2023 868,000.00
Dec 31, 2022 116,000.00
Sep 30, 2022 9.75 Mn
Jun 30, 2022 952,000.00
Mar 31, 2022 11.06 Mn
Dec 31, 2021 11.27 Mn
Sep 30, 2021 1.05 Mn
Jun 30, 2021 11.83 Mn